221 related articles for article (PubMed ID: 33922773)
1. Does Post-Transplant Cytomegalovirus Increase the Risk of Invasive Aspergillosis in Solid Organ Transplant Recipients? A Systematic Review and Meta-Analysis.
Chuleerarux N; Thongkam A; Manothummetha K; Nematollahi S; Dioverti-Prono V; Torvorapanit P; Langsiri N; Worasilchai N; Plongla R; Chindamporn A; Sanguankeo A; Permpalung N
J Fungi (Basel); 2021 Apr; 7(5):. PubMed ID: 33922773
[TBL] [Abstract][Full Text] [Related]
2. The association of cytomegalovirus infection and cytomegalovirus serostatus with invasive fungal infections in allogeneic haematopoietic stem cell transplant recipients: a systematic review and meta-analysis.
Chuleerarux N; Nematollahi S; Thongkam A; Dioverti MV; Manothummetha K; Torvorapanit P; Langsiri N; Worasilchai N; Plongla R; Chindamporn A; Sanguankeo A; Permpalung N
Clin Microbiol Infect; 2022 Mar; 28(3):332-344. PubMed ID: 34752926
[TBL] [Abstract][Full Text] [Related]
3. Associations between invasive aspergillosis and cytomegalovirus in lung transplant recipients: a nationwide cohort study.
Wulff SM; Perch M; Helweg-Larsen J; Bredahl P; Arendrup MC; Lundgren J; Helleberg M; Crone CG
APMIS; 2023 Nov; 131(11):574-583. PubMed ID: 37022293
[TBL] [Abstract][Full Text] [Related]
4. Viral prophylaxis in organ transplant patients.
Slifkin M; Doron S; Snydman DR
Drugs; 2004; 64(24):2763-92. PubMed ID: 15563248
[TBL] [Abstract][Full Text] [Related]
5. Systematic review of ganciclovir pharmacodynamics during the prevention of cytomegalovirus infection in adult solid organ transplant recipients.
Wong DD; van Zuylen WJ; Craig ME; Rawlinson WD
Rev Med Virol; 2019 Mar; 29(2):e2023. PubMed ID: 30556615
[TBL] [Abstract][Full Text] [Related]
6. Ganciclovir-resistant cytomegalovirus infection in solid organ transplant recipients: a single-center retrospective cohort study.
Young PG; Rubin J; Angarone M; Flaherty J; Penugonda S; Stosor V; Ison MG
Transpl Infect Dis; 2016 Jun; 18(3):390-5. PubMed ID: 27037651
[TBL] [Abstract][Full Text] [Related]
7. Burden of cytomegalovirus disease in solid organ transplant recipients: a national matched cohort study in an inpatient setting.
Hakimi Z; Aballéa S; Ferchichi S; Scharn M; Odeyemi IA; Toumi M; Saliba F
Transpl Infect Dis; 2017 Oct; 19(5):. PubMed ID: 28599091
[TBL] [Abstract][Full Text] [Related]
8. Effect of long-term prophylaxis in the development of cytomegalovirus-specific T-cell immunity in D+/R- solid organ transplant recipients.
San-Juan R; Navarro D; García-Reyne A; Montejo M; Muñoz P; Carratala J; Len O; Fortun J; Muñoz-Cobo B; Gimenez E; Eworo A; Sabe N; Meije Y; Martín-Davila P; Andres A; Delgado J; Jimenez C; Amat P; Fernández-Ruiz M; López-Medrano F; Lumbreras C; Aguado JM;
Transpl Infect Dis; 2015 Oct; 17(5):637-46. PubMed ID: 26134282
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of an electronic, patient-focused management system aimed at preventing cytomegalovirus disease following solid organ transplantation.
Ekenberg C; da Cunha-Bang C; Lodding IP; Sørensen SS; Sengeløv H; Perch M; Rasmussen A; Gustafsson F; Wareham NE; Kirkby N; Kjaer J; Helleberg M; Reekie J; Lundgren JD
Transpl Infect Dis; 2020 Apr; 22(2):e13252. PubMed ID: 31997565
[TBL] [Abstract][Full Text] [Related]
10. Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients.
Hodson EM; Craig JC; Strippoli GF; Webster AC
Cochrane Database Syst Rev; 2008 Apr; (2):CD003774. PubMed ID: 18425894
[TBL] [Abstract][Full Text] [Related]
11. The impact of recurrent cytomegalovirus infection on long-term survival in solid organ transplant recipients.
Gardiner BJ; Chow JK; Brilleman SL; Peleg AY; Snydman DR
Transpl Infect Dis; 2019 Dec; 21(6):e13189. PubMed ID: 31581352
[TBL] [Abstract][Full Text] [Related]
12. Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients.
Hodson EM; Barclay PG; Craig JC; Jones C; Kable K; Strippoli GF; Vimalachandra D; Webster AC
Cochrane Database Syst Rev; 2005 Oct; (4):CD003774. PubMed ID: 16235341
[TBL] [Abstract][Full Text] [Related]
13. The incidence of invasive aspergillosis among solid organ transplant recipients and implications for prophylaxis in lung transplants.
Minari A; Husni R; Avery RK; Longworth DL; DeCamp M; Bertin M; Schilz R; Smedira N; Haug MT; Mehta A; Gordon SM
Transpl Infect Dis; 2002 Dec; 4(4):195-200. PubMed ID: 12535262
[TBL] [Abstract][Full Text] [Related]
14. Invasive aspergillosis in solid organ transplant patients: diagnosis, prophylaxis, treatment, and assessment of response.
Neofytos D; Garcia-Vidal C; Lamoth F; Lichtenstern C; Perrella A; Vehreschild JJ
BMC Infect Dis; 2021 Mar; 21(1):296. PubMed ID: 33761875
[TBL] [Abstract][Full Text] [Related]
15. Sensitivity of blood and tissue diagnostics for gastrointestinal cytomegalovirus disease in solid organ transplant recipients.
Fisher CE; Alexander J; Bhattacharya R; Rakita RM; Kirby KA; Boeckh M; Limaye AP
Transpl Infect Dis; 2016 Jun; 18(3):372-80. PubMed ID: 27004439
[TBL] [Abstract][Full Text] [Related]
16. Risk Factors and Outcomes of Ganciclovir-Resistant Cytomegalovirus Infection in Solid Organ Transplant Recipients.
Fisher CE; Knudsen JL; Lease ED; Jerome KR; Rakita RM; Boeckh M; Limaye AP
Clin Infect Dis; 2017 Jul; 65(1):57-63. PubMed ID: 28369203
[TBL] [Abstract][Full Text] [Related]
17. Meta-analysis: the efficacy of strategies to prevent organ disease by cytomegalovirus in solid organ transplant recipients.
Kalil AC; Levitsky J; Lyden E; Stoner J; Freifeld AG
Ann Intern Med; 2005 Dec; 143(12):870-80. PubMed ID: 16365468
[TBL] [Abstract][Full Text] [Related]
18. Epidemiology, risk factors and outcomes of invasive aspergillosis in solid organ transplant recipients in the Swiss Transplant Cohort Study.
Neofytos D; Chatzis O; Nasioudis D; Boely Janke E; Doco Lecompte T; Garzoni C; Berger C; Cussini A; Boggian K; Khanna N; Manuel O; Mueller NJ; van Delden C;
Transpl Infect Dis; 2018 Aug; 20(4):e12898. PubMed ID: 29668068
[TBL] [Abstract][Full Text] [Related]
19. Cytomegalovirus infection is a risk factor for invasive aspergillosis in lung transplant recipients.
Husni RN; Gordon SM; Longworth DL; Arroliga A; Stillwell PC; Avery RK; Maurer JR; Mehta A; Kirby T
Clin Infect Dis; 1998 Mar; 26(3):753-5. PubMed ID: 9524855
[TBL] [Abstract][Full Text] [Related]
20. A pharmacist-driven antimicrobial stewardship intervention targeting cytomegalovirus viremia in ambulatory solid organ transplant recipients.
Wang N; Athans V; Neuner E; Bollinger J; Spinner M; Brizendine K
Transpl Infect Dis; 2018 Dec; 20(6):e12991. PubMed ID: 30184302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
